🇺🇸 biphasic insulin aspart in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Lactic Acidosis — 2 reports (18.18%)
  2. Abdominal Pain Upper — 1 report (9.09%)
  3. Bacterial Test Positive — 1 report (9.09%)
  4. Bronchial Obstruction — 1 report (9.09%)
  5. Carotid Artery Stenosis — 1 report (9.09%)
  6. Chest Pain — 1 report (9.09%)
  7. Culture Urine Positive — 1 report (9.09%)
  8. Cytolytic Hepatitis — 1 report (9.09%)
  9. Diabetic Ketoacidosis — 1 report (9.09%)
  10. Hyperkalaemia — 1 report (9.09%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is biphasic insulin aspart approved in United States?

biphasic insulin aspart does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for biphasic insulin aspart in United States?

Novo Nordisk A/S is the originator. The local marketing authorisation holder may differ — check the official source linked above.